Advertisement

Treatment of Asthma Patients Under Severe Conditions

  • Giuseppe A. Marraro
Conference paper
  • 303 Downloads

Abstract

Asthma is a chronic inflammatory disorder of the airways characterized by an obstruction of airflow. It affects people of all ages and is characterized by repeated attacks of difficulty in breathing. Airway inflammation may cause recurrent or persistent bronchospasm, wheezing, breathlessness, tightness in the chest and coughing, particularly at night, in the early morning, or after exercise.

Keywords

Mechanical Ventilation Continuous Positive Airway Pressure Respir Crit Acute Asthma Pulmonary Surfactant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Brenner BE. Bronchial asthma in adults: presentation to the emergency department. Part I: Pathogenesis, clinical manifestations, diagnostic evaluation, and differential diagnosis. Am J Emerg Med 1983; 1:50–70PubMedCrossRefGoogle Scholar
  2. Brenner BE. Bronchial asthma in adults: presentation to the emergency department. Part II: Sympathomimetics, respiratory failure, recommendations for initial treatment, indications for admission, and summary. Am J Emerg Med 1983b; 1:306–33PubMedCrossRefGoogle Scholar
  3. FitzGerald JM, Macklem P. Proceedings of a workshop on near fatal asthma. Can Respir J 1995; 2:113–26Google Scholar
  4. Williams TJ. Risks factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992; 146(3):607–615PubMedCrossRefGoogle Scholar
  5. DeNicola LK. Treatment of critical status asthmaticus in children. Pediatric Crit Care 1994; 41(6): 1293–1324Google Scholar
  6. McFadden ER Jr, Warren EL. Observations on asthma mortality. Ann Intern Med 1997; 127(2): 142–7PubMedCrossRefGoogle Scholar
  7. Newcomb R. Respiratory failure from asthma. A marker for children with high morbidity and mortality. Am J Dis Child. 1988; 142(10):1041–1044PubMedGoogle Scholar
  8. Spitzer WO. The use of b-agonist and the risk of death and near death from asthma. N Engl J Med 1992; 326(8):501–506PubMedCrossRefGoogle Scholar
  9. Tobin MJ. Asthma, airway biology, and nasal disorders in AJRCCM 2001. Am J Respir Crit Care Med 2002; 165:598–618PubMedCrossRefGoogle Scholar
  10. Hohlfeld JM, Ahlf K, Enhorning G, et al. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999; 159:1803–1809PubMedCrossRefGoogle Scholar
  11. Hohlfeld JM. The role of surfactant in asthma. Respir Res 2002; 3:4–12PubMedCrossRefGoogle Scholar
  12. Kurashima K, Fujimura M, Tsujiura M, Matsuda T. Effect of surfactant inhalation on allergic bronchocontriction in guinea pigs. Clin Exp Allergy 1997, 27:337–342PubMedCrossRefGoogle Scholar
  13. British Thoracic Society, et al. Guidelines for the management of asthma: a summary. BMJ. 1993 Mar 20; 306(6880):776–782CrossRefGoogle Scholar
  14. Huber P et le Groupe Francophone de Réanimation Pédiatrique. Les asthmes aigus graves en reanimation pediatrique. ArchPediatr 1994; 1:346–349Google Scholar
  15. Corbridge TC. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995; 151(5): 1296–1316PubMedCrossRefGoogle Scholar
  16. Downes JJ. Arterial blood gas analysis and acid base desorders in infants and children with status asthmaticus. Pediatrics 1968; 42(2):238–249PubMedGoogle Scholar
  17. Hoonig EG. Chronic obstructive pulmonary disease and asthma. In: Handbook of Mechanical ventilation support. Ed: Perel A and Stock MC. Williams & Wilkins, Baltimore. 1992; pp 227–245Google Scholar
  18. Kurth CD. Obstructive airway diseases in infants and children. In: Neonatal and Pediatric Respiratory Care. Beck Koff Eitzman and Neu. 2nd Edition. Mosby, St Louis. 1993; 102–127Google Scholar
  19. Jain S. Ventilation of patients with asthma and obstructive lung disease. Critical Care Clinics 1998; 14(4):685–705PubMedCrossRefGoogle Scholar
  20. Cox RG. Efficacy, results and complications of mechanical ventilation in children with status asthmaticus. Pediatr Pulmonol 1991; 11:120–126PubMedCrossRefGoogle Scholar
  21. Marraro G. Airway management. In Bissonnette B, Dalens BJ eds. “Principles and practice of pediatric anesthesia” McGraw-Hill Comp. New York 2001; pp778–814Google Scholar
  22. Tuxen DV. The effects of ventilatory pattern on hyperinflation, airway pressures and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987; 136:872–879PubMedCrossRefGoogle Scholar
  23. Tuxen DV. Use of measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma. Am Rev Respir Dis 1992; 146:1136–1142PubMedCrossRefGoogle Scholar
  24. Slutsky AS. Mechanical ventilation. Chest 1993; 104:1833–1859PubMedCrossRefGoogle Scholar
  25. Darioli R. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129(3):385–387PubMedGoogle Scholar
  26. Hicking K, Joyce C. Permissive hypercapnia in ARDS and its effect on tissue oxygenation. Acta Anaesthesiol Scand 1995; 39:201–208CrossRefGoogle Scholar
  27. Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994; 150:1722–1737PubMedCrossRefGoogle Scholar
  28. Tuxen D. Permissive hypercapnia ventilation. Am J Respir Crit Care Med 1994; 150:870–874PubMedCrossRefGoogle Scholar
  29. Marraro G A. Innovative practices of ventilatory support with pediatric patients. Pediatric Critical Care Medicine 2003; 4(1): 8–20PubMedCrossRefGoogle Scholar
  30. Appel D, Karpel JP, Sherman M. Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate. J Allergy Clin Immunol 1989 Jul; 84(1): 90–98PubMedCrossRefGoogle Scholar
  31. Dreyfuss D, Saumon G. Ventilator-induced lung injury:lesson from experimental studies [State of the Art], Am J Respir Crit Care Med 1998; 157:294–330PubMedCrossRefGoogle Scholar
  32. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med. 1992; 18(6):319–321PubMedCrossRefGoogle Scholar
  33. Qvist J. High-level PEEP in severe asthma. N Engl J Med 1982; 18:1347–1348Google Scholar
  34. Shivaram U. Cardiopulmonary responses to continuous positive airway pressure in acute asthma. J Crit Care 1993; 8:87–92PubMedCrossRefGoogle Scholar
  35. Smith TC. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol 1988; 65:1488–1499PubMedGoogle Scholar
  36. Ranieri VM. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am Rev Respir Dis 1993; 147:5–13PubMedCrossRefGoogle Scholar
  37. Bierman CW. Pneumomediastinum and pneumothorax complicating asthma in children. Am J Dis Child 1967; 114:43–47Google Scholar
  38. Van der Touw T. Cardiorespiratory consequences of expiratory chest wall compression during mechanical ventilation and severe hyperinflation. Crit Care Med 1993; 21:1908–1914PubMedCrossRefGoogle Scholar
  39. Rock MJ. Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med 1986; 14(5):514–516PubMedCrossRefGoogle Scholar
  40. Strube PJ. Ketamine by continuous infusion in status asthmaticus. Anesthesia 1986; 41(10): 1087CrossRefGoogle Scholar
  41. L’Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 1987; 16:568–71PubMedCrossRefGoogle Scholar
  42. Bierman MI. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986; 14:832–833PubMedCrossRefGoogle Scholar
  43. Saulnier FF. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med 1990;16:104–107PubMedCrossRefGoogle Scholar
  44. Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995; 107(6): 1576–81PubMedCrossRefGoogle Scholar
  45. Kass JE, Castriotta RJ. Heliox therapy in acute severe asthma. Chest 1995; 107:757–760PubMedCrossRefGoogle Scholar
  46. Downey P, Cox R.. Update on the management of status asthmaticus. Curr Opin Pediatr 1996; 8:226–233PubMedCrossRefGoogle Scholar
  47. Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98:693–698PubMedCrossRefGoogle Scholar
  48. Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in non intubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151:310–314PubMedCrossRefGoogle Scholar
  49. Rishani R, El-Khatib M, Mroueh S. Treatment of severe status asthmaticus with nitric oxide. Pediatr Pulmonol 1999; 28(6):451–453PubMedCrossRefGoogle Scholar
  50. Luchetti M, Casiraghi G, Valsecchi R, Marraro G. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand 1998; 42(7):805–810PubMedCrossRefGoogle Scholar
  51. Luchetti M, Gallini C., Pigna A, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatric Critical Care Medicine 2002; 3(3): 261–268PubMedCrossRefGoogle Scholar
  52. Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Resp Crit Care Med 2000; 162:1251–1256PubMedCrossRefGoogle Scholar
  53. Marraro GA. Surfactant use in severe bronchiolitis. Biol Neonate 2002; 81 (suppl 1):28PubMedCrossRefGoogle Scholar
  54. Kurashima K, Ogawa H, Ohka T, et al. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Aerugi (Jpn J Allergol) 1991, 40:160–163Google Scholar
  55. Heeley EL, Hohlfeld JM, Krug N, Postle AD. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. Am J Physiol (Lung Cell Mol Physiol) 2000, 278:L305-L311Google Scholar
  56. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987, 62:429–437PubMedCrossRefGoogle Scholar
  57. Seeger W, Grube C., Günther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993, 6:971–977PubMedGoogle Scholar
  58. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin Exp Allergy 1996, 26:270–275PubMedCrossRefGoogle Scholar
  59. King D. Extracorporeal membrane oxygenation as emergency treatment for life-threatening acute severe asthma. Postgraduate Med J 1986; 62:855–857CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2003

Authors and Affiliations

  • Giuseppe A. Marraro
    • 1
  1. 1.Anesthesia and Intensive Care Department, Pediatric Intensive Care UnitFatebenefratelli and Ophthalmiatric HospitalMilanItaly

Personalised recommendations